open access

Vol 13, No 5 (2017)
Case report
Published online: 2017-11-15
Get Citation

A patient with metastatic malignant melanoma treated with nivolumab: case report

Paweł Rogala1
DOI: 10.5603/OCP.2017.0027
·
Oncol Clin Pract 2017;13(5):230-232.
Affiliations
  1. Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Skłodowska-Curie Memorial Cancer Centre, Warsaw

open access

Vol 13, No 5 (2017)
CASE REPORT
Published online: 2017-11-15

Abstract

This is a case report of a 41-year-old female patient diagnosed in 2012 with malignant melanoma of the right
cheek. She was treated surgically. In 2013 right-sided cervical lymphadenectomy was performed due to melanoma
metastases. Subsequently, new metastases were found in the lungs, liver, and bones. She was treated with
nivolumab. A partial remission of the disease was noted and response is currently ongoing.

Abstract

This is a case report of a 41-year-old female patient diagnosed in 2012 with malignant melanoma of the right
cheek. She was treated surgically. In 2013 right-sided cervical lymphadenectomy was performed due to melanoma
metastases. Subsequently, new metastases were found in the lungs, liver, and bones. She was treated with
nivolumab. A partial remission of the disease was noted and response is currently ongoing.

Get Citation

Keywords

malignant melanoma; nivolumab; immunotherapy

About this article
Title

A patient with metastatic malignant melanoma treated with nivolumab: case report

Journal

Oncology in Clinical Practice

Issue

Vol 13, No 5 (2017)

Article type

Case report

Pages

230-232

Published online

2017-11-15

DOI

10.5603/OCP.2017.0027

Bibliographic record

Oncol Clin Pract 2017;13(5):230-232.

Keywords

malignant melanoma
nivolumab
immunotherapy

Authors

Paweł Rogala

References (4)
  1. Charakterystyka produktu leczniczego. Niwolumab. EMA 2015.
  2. Robert C, Long GV, Brady B, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med. 2015; 372(4): 320–330.
  3. Rutkowski P, Wysocki PJ, Nasierowska-Guttmejer A. Czerniaki skóry — zasady postępowania diagnostyczno- terapeutycznego w 2016 roku. Onkologia w Praktyce Klinicznej 2015.
  4. Postow MA, Chesney J, Pavlick AC, et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med. 2015; 372(21): 2006–2017.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl